News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
649,058 Results
Type
Article (61476)
Company Profile (84)
Press Release (587498)
Multimedia
Podcasts (62)
Webinars (13)
Section
Business (174694)
Career Advice (2739)
Deals (32525)
Drug Delivery (99)
Drug Development (77078)
Employer Resources (150)
FDA (14998)
Job Trends (14117)
News (306561)
Policy (29207)
Tag
Academia (2895)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (90)
Alliances (43386)
ALS (94)
Alzheimer's disease (1326)
Antibody-drug conjugate (ADC) (116)
Approvals (15007)
Artificial intelligence (275)
Autoimmune disease (24)
Automation (16)
Bankruptcy (296)
Best Places to Work (11059)
BIOSECURE Act (16)
Biosimilars (102)
Biotechnology (62)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (287)
Cancer (2246)
Cardiovascular disease (170)
Career advice (2320)
Career pathing (33)
CAR-T (159)
Cell therapy (442)
Cervical cancer (21)
Clinical research (62785)
Collaboration (813)
Company closure (2)
Compensation (346)
Complete response letters (20)
COVID-19 (2576)
CRISPR (45)
C-suite (271)
Cystic fibrosis (104)
Data (2277)
Decentralized trials (2)
Denatured (26)
Depression (44)
Diabetes (258)
Diagnostics (6191)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (105)
Drug shortages (23)
Duchenne muscular dystrophy (89)
Earnings (61062)
Editorial (41)
Employer branding (18)
Employer resources (132)
Events (95236)
Executive appointments (779)
FDA (16364)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (768)
Gene editing (114)
Generative AI (21)
Gene therapy (312)
GLP-1 (681)
Government (4488)
Grass and pollen (6)
Guidances (154)
Healthcare (18302)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (114)
Indications (28)
Infectious disease (2714)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (98)
Interviews (527)
IPO (14842)
IRA (41)
Job creations (3436)
Job search strategy (1948)
Kidney cancer (10)
Labor market (34)
Layoffs (514)
Leadership (22)
Legal (6621)
Liver cancer (72)
Lung cancer (309)
Lymphoma (148)
Machine learning (9)
Management (53)
Manufacturing (295)
MASH (73)
Medical device (12719)
Medtech (12724)
Mergers & acquisitions (18286)
Metabolic disorders (660)
Multiple sclerosis (81)
NASH (13)
Neurodegenerative disease (88)
Neuropsychiatric disorders (26)
Neuroscience (1863)
NextGen: Class of 2025 (6402)
Non-profit (4353)
Now hiring (16)
Obesity (333)
Opinion (233)
Ovarian cancer (77)
Pain (97)
Pancreatic cancer (84)
Parkinson's disease (144)
Partnered (22)
Patents (246)
Patient recruitment (115)
Peanut (50)
People (59705)
Pharmaceutical (23)
Pharmacy benefit managers (16)
Phase I (19756)
Phase II (27716)
Phase III (20217)
Pipeline (1304)
Policy (139)
Postmarket research (2480)
Preclinical (8435)
Press Release (67)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (250)
Rare diseases (370)
Real estate (6023)
Recruiting (61)
Regulatory (20215)
Reports (34)
Research institute (2400)
Resumes & cover letters (405)
Rett syndrome (6)
RNA editing (3)
RSV (35)
Schizophrenia (72)
Series A (132)
Series B (89)
Service/supplier (10)
Sickle cell disease (52)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3362)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (33)
The Weekly (34)
Vaccines (675)
Venture capitalists (35)
Weight loss (210)
Women's health (31)
Worklife (19)
Date
Today (169)
Last 7 days (948)
Last 30 days (2920)
Last 365 days (30412)
2025 (11235)
2024 (32399)
2023 (36503)
2022 (46763)
2021 (51694)
2020 (50883)
2019 (44983)
2018 (34233)
2017 (30809)
2016 (30219)
2015 (35605)
2014 (28549)
2013 (25125)
2012 (26439)
2011 (26645)
2010 (25109)
Location
Africa (875)
Alabama (55)
Alaska (6)
Arizona (175)
Arkansas (14)
Asia (38138)
Australia (6868)
California (5814)
Canada (1898)
China (502)
Colorado (255)
Connecticut (265)
Delaware (150)
Europe (88794)
Florida (889)
Georgia (208)
Idaho (57)
Illinois (562)
India (25)
Indiana (290)
Iowa (10)
Japan (162)
Kansas (97)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (854)
Massachusetts (4196)
Michigan (228)
Minnesota (351)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (62)
New Hampshire (61)
New Jersey (1701)
New Mexico (29)
New York (1689)
North Carolina (991)
North Dakota (9)
Northern California (2543)
Ohio (200)
Oklahoma (15)
Oregon (36)
Pennsylvania (1283)
Puerto Rico (13)
Rhode Island (31)
South America (1179)
South Carolina (20)
South Dakota (1)
Southern California (2219)
Tennessee (99)
Texas (935)
United States (22134)
Utah (180)
Virginia (147)
Washington D.C. (52)
Washington State (525)
West Virginia (3)
Wisconsin (62)
649,058 Results for "university of texas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
University of Texas Permian Basin’s Water In Energy Conference Returns to Midland with Exciting New Opportunities
January 21, 2025
·
2 min read
Press Releases
Feinstein Institutes, Bioelectronic Medicine honor three University of Texas at Dallas researchers with 2024 Cerami Award
February 4, 2025
·
5 min read
Job Trends
9 Life Sciences Companies Hiring in Texas
Looking for a job in Texas? Check out these nine companies hiring life sciences professionals like you.
August 8, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Texas Children’s Hospital and UT MD Anderson Announce Joint Venture to End Childhood Cancer
February 19, 2025
·
4 min read
Real estate
Texas Life Sciences Redevelopment Project Moves Closer to Reality
In Texas, the Plano City Council approved a development agreement that supports a planned project that would bring over 3 million square feet of life sciences space to the area.
August 29, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
March 20, 2025
·
6 min read
Bankruptcy
16 Years And 3 Texas Two-Steps Later, J&J’s Talc Lawsuit Awaits Key Ruling
Johnson & Johnson has been fighting thousands of lawsuits over its now-discontinued talc products for 16 years. A pending judge’s ruling could finally put the issue to bed once and for all.
March 12, 2025
·
4 min read
·
Annalee Armstrong
Biotech Beach
ChemDiv Forges Strategic Partnership with The University of Texas Medical Branch (UTMB) to Expand Its High-throughput Screening Research Capabilities
ChemDiv announces a strategic collaboration with the University of Texas Medical Branch to facilitate the expansion of its inventory and advance the institution’s High-throughput Screening research programs.
December 28, 2023
·
1 min read
Policy
Actinium Announces KOL Webinar to Highlight Recently Announced Iomab-ACT Trial with Leading FDA Approved Commercial CAR T-Cell Therapy Being Led by the University of Texas Southwestern
Actinium Pharmaceuticals, Inc. announced it will host a KOL call on Monday, May 20, 2024, at 8:00 AM ET to provide updates and highlight its recently announced clinical trial to study Iomab-ACT with a leading FDA approved CAR-T cell therapy at the University of Texas Southwestern.
May 7, 2024
·
6 min read
Pain
Lexicon to Advance Non-Opioid Painkiller Despite Mid-Stage Trial Failure
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III trials before long.
March 3, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 64,906
Next
